PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Jan-2026 ERMA Systems Launches Q1 AI Pilot with Life Science Innovators, Welcomes Brandon Schlette to Advisory Board Businesswire
15-Jan-2026 Nicoya Life Sciences Announces Launch of Multichannel Benchtop SPR Instrument, Aimed to Deliver Publication-Quality, Real-time Kinetic Data to Small and Midsize Research Labs Businesswire
15-Jan-2026 VaultBio Appoints Raffi Siyahian as President, Agency Services and Audience Activation Businesswire
15-Jan-2026 QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials Businesswire
15-Jan-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
15-Jan-2026 Wendy Gregg Builds Sustainable Healthcare Programs for Underserved Populations ACCESS Newswire
15-Jan-2026 InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease Businesswire
15-Jan-2026 Advanced Medical Solutions Group plc Full Year 2025 Trading Update Advanced Medical Solutions Group
15-Jan-2026 Sobi's 2025 annual revenue and adjusted EBITA margin exceed previous outlook Sobi
15-Jan-2026 Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe Novo Nordisk Foundation
15-Jan-2026 Functional Gut launches dedicated GI Clinical Trials Division to accelerate digestive health research Functional Gut
15-Jan-2026 Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy Santhera
15-Jan-2026 BODYWELLE Now Offers FDA-Approved Oral Wegovy, the First Oral GLP-1 for Medical Weight Management ACCESS Newswire
15-Jan-2026 Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema Businesswire
15-Jan-2026 NCQA Appoints Dana Erickson and Kate McEvoy to Board of Directors ACCESS Newswire
15-Jan-2026 AMIA Welcomes Philip Payne, PhD, FACMI, FAMIA, as New Board President ACCESS Newswire
15-Jan-2026 CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR) ACCESS Newswire
15-Jan-2026 Conference Call on Year-End Report 2025 ACCESS Newswire
15-Jan-2026 ModMed Sweeps 2026 Black Book Awards, Ranked #1 Across 11 Specialty EHR Categories ACCESS Newswire
15-Jan-2026 enVVeno Medical Announces Reverse Stock Split ACCESS Newswire